| FDA
Takes Action Against Compounded Menopause Hormone Therapy Drugs
In a press release January 9, 2008, the U.S. Food and Drug Administration (FDA) announced that it has sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency. FDA is concerned that unfounded claims like these mislead women and health care professionals. |
